<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="ppub"/></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS162888</article-id><article-id pub-id-type="doi">10.1101/2020.09.03.281600</article-id><article-id pub-id-type="archive">PPR210310</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group><subj-group subj-group-type="europepmc-category"><subject>Covid-19</subject></subj-group></article-categories><title-group><article-title>Boosting the analysis of protein interfaces with Multiple Interface String Alignment: <italic>illustration on the spikes of coronaviruses</italic></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bereux</surname><given-names>S.</given-names></name><xref ref-type="aff" rid="A1">*</xref></contrib><contrib contrib-type="author"><name><surname>Delmas</surname><given-names>B.</given-names></name><xref ref-type="aff" rid="A2">‚Ä†</xref></contrib><contrib contrib-type="author"><name><surname>Cazals</surname><given-names>F.</given-names></name><xref ref-type="aff" rid="A3">‚Ä°</xref></contrib></contrib-group><aff id="A1"><label>*</label>Universit√© C√¥te d‚ÄôAzur, Inria, France, √âcole polytechnique</aff><aff id="A2"><label>‚Ä†</label>INRAe</aff><aff id="A3"><label>‚Ä°</label>Universit√© C√¥te d‚ÄôAzur, Inria, France</aff><pub-date pub-type="nihms-submitted"><day>20</day><month>01</month><year>2023</year></pub-date><pub-date pub-type="preprint"><day>03</day><month>09</month><year>2020</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">We introduce <italic>Multiple Interface String Alignment</italic> (MISA), a visualization tool to display coherently various sequence and structure based statistics at protein-protein interfaces (SSE elements, buried surface area, ŒîASA, B factor values, etc). The amino-acids supporting these annotations are obtained from Voronoi interface models. The benefit of MISA is to collate annotated sequences of (homologous) chains found in different biological contexts <italic>i.e.</italic> bound with different partners or unbound. The aggregated views MISA/SSE, MISA/BSA, MISA/ ŒîASAetc make it trivial to identify commonalities and differences between chains, to infer key interface residues, and to understand where conformational changes occur upon binding. As such, they should prove of key relevance for knowledge based annotations of protein databases such as the Protein Data Bank.</p><p id="P2">Illustrations are provided on the receptor binding domain (RBD) of coronaviruses, in complex with their cognate partner or (neutralizing) antibodies. MISA computed with a minimal number of structures complement and enrich findings previously reported.</p><p id="P3">The corresponding package is available from the Structural Bioinformatics Library (<ext-link ext-link-type="uri" xlink:href="http://sbl.inria.fr">http://sbl.inria.fr</ext-link>)</p></abstract><kwd-group kwd-group-type="author"><kwd>protein interface</kwd><kwd>multiple sequence alignments</kwd><kwd>interface comparison</kwd><kwd>interface RMSD</kwd><kwd>Struc-tural Bioinformatics Library</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><label>1</label><title>Introduction</title><sec id="S2"><title>Protein complexes and their interface</title><p id="P4">Understanding the stability and the specificity of protein inter-actions is a fundamental problem [<xref ref-type="bibr" rid="R1">1</xref>], both to unveil complex biological mechanisms and design therapeutics. From the thermodynamic standpoint, the binding affinity or equivalently the dissociation free energy, boils down to compute the ratio of three so-called partition functions [<xref ref-type="bibr" rid="R2">2</xref>]. These partition functions are themselves defined from the potential energy of the system, which in particular encodes interaction energies at play between atoms (electrostatic interactions, non covalent interactions, bonded interactions). This observation does not settle the question though, as the huge dimensionality of the system involving the biomolecules and the solvent precludes calculations, except maybe for small systems using massive calculations [<xref ref-type="bibr" rid="R3">3</xref>, <xref ref-type="bibr" rid="R4">4</xref>].</p><p id="P5">This observation also explains the success of geometric models based on distances, surfaces and volumes, which originate with the seminal work of Richards for individual molecules [<xref ref-type="bibr" rid="R5">5</xref>] and Janin for complexes [<xref ref-type="bibr" rid="R6">6</xref>]. Such models proved instrumental to understand the specificity and affinity of interactions [<xref ref-type="bibr" rid="R1">1</xref>]; in some cases, they even proved good enough to estimate binding energies up to (of the order of) 1.4kcal/mol [<xref ref-type="bibr" rid="R7">7</xref>]. To study two partners forming a complex, such models require identifying the atoms in contact. To this end, Voronoi models, be their affine [<xref ref-type="bibr" rid="R8">8</xref>] or curved [<xref ref-type="bibr" rid="R9">9</xref>], provide a parameter free approach to model interfaces, and affine models in particular give a direct access to various structural parameters including the number of interface atoms and residues, the buried surface area, the number of binding patches, or the interface curvature [<xref ref-type="bibr" rid="R8">8</xref>].</p><p id="P6">These parameters are typically sufficient to compare interfaces for cases belonging to various protein families (protease-inhibitors, enzyme-substrate, antibody-antigen, signal transduction, etc) [<xref ref-type="bibr" rid="R10">10</xref>], or cases within a protein family [<xref ref-type="bibr" rid="R11">11</xref>]. On the other hand, in processing complexes specifically addressing a biological case, say a family of homologous proteins targeting the same cognate partner, it is also critical to study correlations between structural parameters describing interfaces and sequence related pieces of information. For sequences, the natural route in to resort to multiple sequence alignments (MSA) [<xref ref-type="bibr" rid="R12">12</xref>].</p></sec><sec id="S3"><title>Multiple Interface String Alignment (MISA)</title><p id="P7">In this work, we introduce MISAs, a visualization tool to display coherently various sequence and structure based statistics at protein-protein interfaces (SSE elements, buried surface area, ŒîASA, B factor values, etc). The benefit of MISAs is to collate annotated sequences of (homologous) chains found in different biological contexts (unbound or bound with different partners).</p><p id="P8">We illustrate the interest to analyse the receptor-binding domain (RBD) or the virus SARS-Cov-2 causing the covid19 outbreak. First, we compare the receptor-binding domains (RBD) of SARS-Cov-1 and SARS-Cov-2 (two phylogenetically-related betacoronavirus). Second, we compare the interfaces of their RBD bound to their common cell receptor and with antibodies.</p><p id="P9">The implementation of MISAs available in the SBL (<ext-link ext-link-type="uri" xlink:href="http://sbl.inria.fr">http://sbl.inria.fr</ext-link>, [<xref ref-type="bibr" rid="R13">13</xref>]).</p></sec></sec><sec id="S4"><label>2</label><title>Methods: MISAs ‚Äì multiple interface string alignments</title><sec id="S5"><label>2.1</label><title>MISA</title><p id="P10">We assume a collection of crystal structures of the bound and unbound types. We call a polypeptide chain in these structures a <italic>chain instance</italic>. We also assume that a multiple sequence alignment is available for the sequences of the instances of interest. Practically, we expect two settings: (i) chain instances with identical sequence: since numberings used in the respective PDB files are identical, the identity alignment is used; (ii) homologous proteins: a multiple sequence alignment providing a coherent numbering of amino acids (a.a.) is taken for granted.</p><p id="P11">The terminology used in the sequel is as follows. We study chain instances and compare them against one another using one <italic>MISA</italic> for each so-called <italic>MISA id</italic>. A MISA is based on <italic>interface strings</italic> (i-string), which following conventions for sequence alignments, use the one-letter code of (a.a.) plus three additional symbols {_ ‚àó ‚àí}. We now detail these concepts.</p><sec id="S6"><title>MISA id</title><p id="P12">A complex <italic>C<sub>i</sub></italic> is specified by two sorted lists of chains ids <italic>i.e. C<sub>i</sub></italic> = ({<italic>A<sub>j</sub></italic>}, {<italic>B<sub>j</sub></italic>}) for the two partners; each list is endowed with a partner/structure name. Likewise, an unbound structure is specified by a sorted list of chain ids <italic>U<sub>i</sub></italic> = {<italic>A<sub>j</sub></italic>}, and is also given a partner/structure name (<italic>e.g.</italic> antibody, antigen, etc.) We consider a collection of complexes ùíû = {<italic>C<sub>i</sub></italic>}, and optionally a collection of unbound structures ùí∞ = {<italic>U<sub>i</sub></italic>}. The minimal setup is naturally that of a single complex without any unbound structure.</p><p id="P13">Our goal is two build one MISA for each so-called MISA id, which we formally define as:</p><p id="P14"><bold>Definition. 1</bold> <italic>The</italic> MISA id <italic>of a chain in a complex or unbound structure is the string defined by the structure name followed by the index of the chain in its sorted list</italic> {<italic>A<sub>j</sub></italic>} <italic>or</italic> {<italic>B<sub>j</sub></italic>}. <italic>(Nb: by convention, indices start at 0.)</italic></p><p id="P15">Note that because of the sortedness, a given chain gets the same MISA id in a complex or unbound structure.</p><p id="P16"><bold>Example 1</bold> <italic>Consider two antibody-antigen complexes</italic>. <italic>C</italic><sub>1</sub> = ({<italic>H, L</italic>}, {<italic>A</italic>}), <italic>C</italic><sub>2</sub> = ({<italic>M, N</italic>}, {<italic>B</italic>}), <italic>each involving the heavy chains (chains H and M), the light chains (chains L and N), and the antigen (chains A and B). The two structure names are thus antibody (IG for short) and antigen (Ag for short). The MISA id of the heavy chain is IG_0, that of the light chain IG_1, and that of the antigen Ag_0.</italic></p></sec><sec id="S7"><title>Voronoi interface in a binary complex</title><p id="P17">The two lists of chains in the specification of a complex <italic>C<sub>i</sub></italic> define the so-called partners in the complex, called <italic>A</italic> and <italic>B</italic> for short. In the sequel, we build the Voronoi interface for these partners, using the Voronoi (power) diagram of the solvent accessible model [<xref ref-type="bibr" rid="R8">8</xref>, <xref ref-type="bibr" rid="R1">1</xref>, <xref ref-type="bibr" rid="R14">14</xref>]. More precisely, recall that the Voronoi model identifies pairs of atoms, one on each partner, which are either directly in contact as their Voronoi cells are neighbor, or are contacting a common crystallographic water molecule. Therefore, an a.a. contributing at least one interface atom is called an interface residue/a.a..</p><p id="P18">Practically, we use the sbl-intervor-ABW-atomic.exe executable from the package Space_filling_model of the Structural Bioinformatics Library ([<xref ref-type="bibr" rid="R13">13</xref>], <ext-link ext-link-type="uri" xlink:href="http://sbl.inria.fr">http://sbl.inria.fr</ext-link>).</p></sec><sec id="S8"><title>Interface strings (i-strings)</title><p id="P19">In the sequel, we present MISAs informally, referring the reader to SI Section <italic>Supplemental: formal specification of the method</italic>. We represent each chain instance with a so-called <italic>interface string</italic> encoding properties of its interface amino acids. The interface string of a chain instance is a character string with one character per residue, and is actually defined from all instances with the same MISA id. To build this character string, we first build a <italic>consensus interface</italic> based on all Voronoi interfaces of all complexes in the set ùíû. At each position of the consensus interface, the most frequent residue observed in all the bound structures is chosen as the consensus residue‚Äìwith ties broken using the alphabetical order of the one letter code of a.a.. Using this consensus interface, the residues of a given chain instance (bound or unbound) are assembled into the so-called interface string:</p><p id="P20"><bold>Definition. 2</bold> <italic>The</italic> interface string <italic>(i-string) of a chain instance is the string with one character per amino acid, defined as follows:</italic> <list list-type="simple" id="L1"><list-item><label>1</label><p id="P21">Residue not part of the consensus interface :</p><list list-type="simple" id="L2"><list-item><label>‚Ä¢</label><p id="P22">Displayed with a dash ‚Äú-‚Äù if it is part of the crystal structure, and underscore ‚Äú-‚Äù otherwise.</p></list-item></list></list-item><list-item><label>2</label><p id="P23">Residue part of the consensus interface:</p><list list-type="simple" id="L3"><list-item><label>‚Ä¢</label><p id="P24">Residue not found in the crystal structure: displayed with the star ‚Äô*‚Äô.</p></list-item><list-item><label>‚Ä¢</label><p id="P25">Residue found at the interface for this particular chain: displayed with the uppercase one letter code if the a.a. matches the consensus a.a., or with the lowercase letter otherwise.</p></list-item><list-item><label>‚Ä¢</label><p id="P26">Residue not found at the interface for this particular chain, even though the corresponding position contributes to the consensus interface (for other chains): displayed in an italicized uppercase/low-ercase letter. (Note that this is the case for all residues of unbound structures‚Äìas no partner implies no interface.)</p></list-item></list></list-item></list></p><p id="P27">Practically, it is often sound to restrict the study to a range of amino-acids on the chains studied, whence the following:</p><p id="P28"><bold>Definition. 3</bold> <italic>A</italic> window series <italic>for a MISA id is a sequence of integer ranges of residue ids</italic> {(<italic>B<sub>i</sub>, E<sub>i</sub></italic>)} <italic>used to restrict the display of the i-string.</italic></p></sec><sec id="S9"><title>MISA</title><p id="P29">We use the MSA to align the symbols of interface strings, yielding:</p><p id="P30"><bold>Definition. 4</bold> <italic>The</italic> MISA <italic>of all chain instances in</italic> ùíû ‚à™ ùí∞ <italic>with the same MISA id is the multiple alignment of their interface strings.</italic></p></sec></sec><sec id="S10"><label>2.2</label><title>Colored MISAs</title><p id="P31">We further color the letters of a MISA to encode properties of biological/biophysical interest.</p><sec id="S11"><title>MISA/SSE: coloring based on Secondary Structure Elements</title><p id="P32">The type of SSE a given a.a. belongs to is especially useful when comparing bound and unbound structures, to assess perturbations in the hydrogen bonding network. Practically, we use the dictionary of SSE from [<xref ref-type="bibr" rid="R15">15</xref>].</p></sec><sec id="S12"><title>MISA/BSA: coloring based on Buried Surface Area</title><p id="P33">Consider a chain instance in a complex. The BSA of this chain is defined as the accessible surface area (ASA) [<xref ref-type="bibr" rid="R5">5</xref>] of this chain in the partner alone minus the ASA of the chain in the complex. We report the BSA on a per residue basis, computed using the algorithm from [<xref ref-type="bibr" rid="R16">16</xref>].</p><p id="P34"><bold>Remark 1</bold> <italic>The Voronoi interface model identifies</italic> privileged <italic>contacts between atoms of the partners. Interestingly, selected interface atoms, generally backbone atoms, can be buried within their own subunit [<xref ref-type="bibr" rid="R17">17</xref>]. Since such atoms do not have any BSA (they do not have ASA in their own subunit), a residue containing only such atoms is an interface residue for which the BSA information is irrelevant.</italic></p></sec><sec id="S13"><title>MISA/ ŒîASA: coloring based on the variation of accessible surface area</title><p id="P35">A limitation of the BSA is that its calculation uses the geometry of the bound structure only. The calculation is thus oblivious to conformational changes which may be at play in case of induced fit or conformer selection. To mitigate the previous plot, we also provide the so-called Œî ASAcoloring scheme.</p><p id="P36">Consider an interface partner <italic>P</italic> (= <italic>A</italic> or <italic>B</italic>), in the complex, and consider the i-th residue of one of its chains. Let <italic>AS</italic> <inline-formula><mml:math id="M1"><mml:msubsup><mml:mi>A</mml:mi><mml:mi>i</mml:mi><mml:mi>b</mml:mi></mml:msubsup></mml:math></inline-formula> be the ASA of this i-th residue in the structure involving only the chains defining partner <italic>P</italic> . Also denote <inline-formula><mml:math id="M2"><mml:mrow><mml:msubsup><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>A</mml:mi><mml:mi>S</mml:mi><mml:mi>A</mml:mi></mml:mrow><mml:mo stretchy="true">¬Ø</mml:mo></mml:mover></mml:mrow><mml:mi>i</mml:mi><mml:mi>u</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula> the average ASA of the i-th residue in unbound structures with the same MISA id. We compute for the i-th residue of a bound structure the quantity <inline-formula><mml:math id="M3"><mml:mi>A</mml:mi><mml:mi>S</mml:mi><mml:msubsup><mml:mi>A</mml:mi><mml:mi>i</mml:mi><mml:mi>b</mml:mi></mml:msubsup><mml:mo>-</mml:mo><mml:msubsup><mml:mover><mml:mrow><mml:mi>A</mml:mi><mml:mi>S</mml:mi><mml:mi>A</mml:mi></mml:mrow><mml:mo>¬Ø</mml:mo></mml:mover><mml:mi>i</mml:mi><mml:mi>u</mml:mi></mml:msubsup></mml:math></inline-formula> and display it with a color map.</p><p id="P37"><bold>Remark 2</bold> <italic>The quantity</italic> <inline-formula><mml:math id="M4"><mml:mi>A</mml:mi><mml:mi>S</mml:mi><mml:msubsup><mml:mi>A</mml:mi><mml:mi>i</mml:mi><mml:mi>b</mml:mi></mml:msubsup><mml:mo>-</mml:mo><mml:msubsup><mml:mover><mml:mrow><mml:mi>A</mml:mi><mml:mi>S</mml:mi><mml:mi>A</mml:mi></mml:mrow><mml:mo>¬Ø</mml:mo></mml:mover><mml:mi>i</mml:mi><mml:mi>u</mml:mi></mml:msubsup></mml:math></inline-formula> <italic>is undefined when the corresponding residues are absent in the unbound crystal structures (* in i-string).</italic></p></sec><sec id="S14"><title>MISA/B-factor: coloring based on B-factors</title><p id="P38">The B-factors reflects the atomic thermal motions. Selected recent crystal structures report this information as a 3x3 ANISOU matrix (the anisotropic B-factor). In order to have a single quantity for all the crystals, the ANISOU matrix <italic>B<sub>anisou</sub></italic> is converted into B-factor thanks to the formula <italic>B<sub>factor</sub></italic> = trace(<italic>B<sub>anisou</sub></italic>)/3 [<xref ref-type="bibr" rid="R18">18</xref>]. Optionally, one can choose to normalize the B-factor with respect to (i) all the residues in the chain, or (ii) all the displayed residues.</p></sec></sec><sec id="S15"><label>2.3</label><title>Availability and practical matters</title><p id="P39">MISAs are implemented within the Multiple_interface_string_alignment package of the Structural Bioinformatics Library ([<xref ref-type="bibr" rid="R13">13</xref>], <ext-link ext-link-type="uri" xlink:href="http://sbl.inria.fr">http://sbl.inria.fr</ext-link>), see <ext-link ext-link-type="uri" xlink:href="https://sbl.inria.fr/doc/Multiple_interface_string_alignment-user-manual.html">https://sbl.inria.fr/doc/Multiple_interface_string_alignment-user-manual.html</ext-link>.</p><p id="P40">The calculation and the analysis of MISAs is based on four scripts‚Äìsee online documentation: <list list-type="simple" id="L4"><list-item><label>‚Ä¢</label><p id="P41">sbl-misa.py: building MISAs from a description of complexes and possibly unbound structures.</p></list-item><list-item><label>‚Ä¢</label><p id="P42">sbl-misa-mix.py: mixing selected colored MISAs into a single (html) file.</p></list-item><list-item><label>‚Ä¢</label><p id="P43">sbl-misa-bsa.py: displaying the BSA of all (or selected user defined) residues.</p></list-item><list-item><label>‚Ä¢</label><p id="P44">sbl-misa-diff.py: comparing i-strings and associated properties (in particular BSA) of two interfaces. Has two modes: comparing two i-strings; comparing one i-string and a list of interface residues typically coming from a publication.</p></list-item></list></p><p id="P45">Illustration of these scripts to investigate the questions discussed in the next section are provided in the jupyter notebook which accompanies our software.</p></sec></sec><sec id="S16"><label>3</label><title>Results: studying the receptor-binding domain (RBD) of coronaviruses</title><p id="P46">Similarly to other enveloped viruses, the SARS-Cov-2 virus enters cells using fusion proteins. Having recalled the known facts on this mechanism, we show that MISAs are helpful in two respects: (i) to automate such studies and refine some of the findings reported so far, and (ii) to provide a coherent view of several sequence-structure based statistics, which is instrumental in particular to understand the binding affinity of SARS-Cov-2 RBD for its target.</p><sec id="S17"><label>3.1</label><title>Biological problem</title><p id="P47">Coronavirus entry into cells is mediated by the so-called spike that is responsible for receptor binding and membrane fusion [<xref ref-type="bibr" rid="R19">19</xref>, <xref ref-type="bibr" rid="R20">20</xref>]. The covid19 outbreak triggered an impressive number of structural studies on the entry of SARS-Cov-2, namely [<xref ref-type="bibr" rid="R21">21</xref>] [<xref ref-type="bibr" rid="R22">22</xref>] [<xref ref-type="bibr" rid="R23">23</xref>] [<xref ref-type="bibr" rid="R24">24</xref>] [<xref ref-type="bibr" rid="R25">25</xref>] [<xref ref-type="bibr" rid="R26">26</xref>] [<xref ref-type="bibr" rid="R27">27</xref>]. Interactions between the spikes of SARS-Cov-2 with antibodies have also studied [<xref ref-type="bibr" rid="R28">28</xref>],[<xref ref-type="bibr" rid="R29">29</xref>], [<xref ref-type="bibr" rid="R30">30</xref>]. These papers naturally unveiled critical aspects of this complex process, based on experiments and also sequence based and structure based analysis.</p><p id="P48">Spikes are homotrimers of the protein S [<xref ref-type="bibr" rid="R31">31</xref>, <xref ref-type="bibr" rid="R32">32</xref>]. Each chain consists of two domains S1 and S2, separated by cleavage sites denoted S1/2 and S2‚Äô [<xref ref-type="bibr" rid="R33">33</xref>, <xref ref-type="bibr" rid="R27">27</xref>, <xref ref-type="bibr" rid="R29">29</xref>]. Domain S1 contains the receptor-binding domain (RBD), while domain S2 contains the machinery responsible for the fusion of the virus envelope with the membrane of the cell. In short, the main steps of the mechanism are as follows [<xref ref-type="bibr" rid="R33">33</xref>, <xref ref-type="bibr" rid="R23">23</xref>]: (1) Attachment of the RBD to its target thanks to the receptor binding-motif (RBM), (2) proteolysis cleavage/activation at S1/S2 removing the S1 subunit, (3) second cleavage at S2‚Äô, refolding of fusion machinery - anchoring of fusion peptide into the target membrane, (4) membrane fusion and genome delivery into the cytoplasm. In human, both SARS-Cov-1 and SARS-Cov-2 targets ACE2 [<xref ref-type="bibr" rid="R26">26</xref>], a membrane bound enzyme catalysing the hydrolysis of angiotensin II into angiotensin, as a receptor to enter into cells. The following facts are noticeable [<xref ref-type="bibr" rid="R23">23</xref>]. The virulence of SARS-Cov-2 owes in particular to the presence of a polybasic cleavage site (insertion of three R) collated to the usual S1/S2 cleavage site. The RBD of SARS-Cov-2 stands up less often than that of SARS-Cov-1, which likely favors evasion from the immune system. (Nb: the two conformations are called up/down or closed/open.) This also disfavors binding to the target (binding in the down configuration yields steric clashes), but the lesser proportion of RBD standing up is <italic>rescued</italic> by a higher binding affinity for ACE2 [<xref ref-type="bibr" rid="R23">23</xref>]. Interestingly, a phylogenetically distant human alphacoronavirus, HCoV-NL63 also targets ACE2 as a receptor.</p><p id="P49">In the following, we illustrate the ability of interface string and MISAs to shed light on these complex facts. In doing so, our goal is a presentation of the merits of MISAs, rather than an arbitration of the merits of different publications which investigated the same systems. For this reason, we use a minimal number of crystal structures to get informative MISAs, namely two bound and two unbound structures, choosing those with the highest resolution. As we shall see, even such a simple study sheds new light on a number of published facts.</p></sec><sec id="S18"><label>3.2</label><title>Comparing the RBD of SARS-Cov-1 and SARS-Cov-2 in complex with ACE2</title><sec id="S19"><title>Baseline</title><p id="P50">The spikes of SARS-Cov-1 and SARS-Cov-2 are highly homologous proteins binding ACE2. Pairwise alignment shows that the overall percent protein sequence identity is about 76% [<xref ref-type="bibr" rid="R34">34</xref>]. The S1 subunit is less conserved (64% identity) than S2 (90% identity). Within S1, the receptor-binding domain (RBD) is 74% identical. The initial analysis of the complex between the RBM of SARS-Cov-1 and its target ACE2 was first carried out in [<xref ref-type="bibr" rid="R35">35</xref>]. In this work, it is noted that the BSA at the interface is ‚àº 1700√Ö<sup>2</sup>, and that the interface involves 18 a.a. on the receptor side and 14 a.a. on the spike side. These analysis are extended to SARS-Cov-2 and other SARS viruses, in particular in [<xref ref-type="bibr" rid="R25">25</xref>, SI <xref ref-type="supplementary-material" rid="SD1">Fig 1</xref>], [<xref ref-type="bibr" rid="R24">24</xref>, <xref ref-type="fig" rid="F2">Fig 2B</xref>], and [<xref ref-type="bibr" rid="R27">27</xref>, <xref ref-type="fig" rid="F2">Fig 2C</xref>]. These recent publications take the 14 a.a. identified in [<xref ref-type="bibr" rid="R35">35</xref>] for granted.</p><p id="P51">Note that in furthering these analysis, we sometimes refer to the jupyter notebook which accompanies our software, and propose selected analysis using the four scripts of the Multiple_interface_string_alignment package.</p></sec><sec id="S20"><title>Whole Voronoi interfaces</title><p id="P52">The Voronoi interface calculation yields comparable results (<xref ref-type="fig" rid="F1">Figs. 1</xref> and <xref ref-type="fig" rid="F2">2</xref>). For SARS-Cov-1 (PDB: 2ajf, RBD: chain E, ACE2: chain A), one obtains 246 interface atoms making up 2 binding patches, and defining overall 414 pairwise contacts. For SARS-Cov-2 (PDB 6m0j, RBD: chain E, ACE2: chain A), one gets 212 interface atoms also disposed on two binding patches, and defining overall 371 pairwise contacts. The two interface patches correspond to the transition between a beta sheet and loops on the RBD (<xref ref-type="fig" rid="F1">Fig. 1(B,C)</xref>), dotted line-segments). Moving to interface strings (<xref ref-type="fig" rid="F2">Fig. 2</xref>, we note that the RBD contribution is is characterized by five main stretches along the backbone. Interestingly, two stretches (yellow and red) span the whole interface, crossing on top of one another in a X like figure (<xref ref-type="fig" rid="F1">Fig. 1(C)</xref>).</p></sec><sec id="S21"><title>Buried surface area</title><p id="P53">The BSA is essentially proportional to the number of interface atoms [<xref ref-type="bibr" rid="R1">1</xref>], and is also a key parameter to estimate binding affinities [<xref ref-type="bibr" rid="R36">36</xref>, <xref ref-type="bibr" rid="R7">7</xref>].</p><p id="P54">We first inspect BSA values obtained for two complexes in each case (<xref ref-type="supplementary-material" rid="SD1">SI Figs. 5 and 6</xref>), and compare them against the aforementioned 1700√Ö<sup>2</sup>: SARS-Cov-1: BSA(2ajf chains E+A)=925+888=1813√Ö<sup>2</sup>; BSA(2ajf, chains F+B)=864+817=1681 √Ö<sup>2</sup>; SARS-Cov-2: BSA(6m0j chains E+A)=887+843=1730√Ö<sup>2</sup>; BSA(6lzg, chains B+A)=1120+1098=2218√Ö<sup>2</sup>). While the values are coherent for SARS-Cov-1, it appears that the complex found in 6lzg features 30% more BSA. Inspecting the number of interface atoms readily provides the explanation (output of sbl-intervor-ABW-atomic.exe, see jupyter notebook): for 6lzg, one get 156 interface atoms for the RBD, 164 interface atoms for ACE2, and 22 water molecules sandwiched between the partners; these numbers drop to 101, 110 and 1 respectively for 6m0j. This reminds us a well known fact, namely that solvation by water molecules with low temperature factors (80 units in our case) may significantly change the interface model [<xref ref-type="bibr" rid="R8">8</xref>].</p><p id="P55">Beyond these global values, MISA/BSA gather BSA values for all atoms of the same a.a. (<xref ref-type="supplementary-material" rid="SD1">SI Fig. 5</xref>).</p><p id="P56">Two interesting facts emerge. First, both for SARS-Cov-1 and SARS-Cov-2, the residues which bury the largest ASA are found at both endpoints of the fifth stretch (<xref ref-type="supplementary-material" rid="SD1">SI Fig. 5</xref>), contributing to the <italic>stabilization</italic> of the interface. For SARS-Cov-1, one notes in particular: Y475, T486, Y491; and for SARS-Cov-2: F486, Y489, T500, Y505. We also note that some of these a.a. bury a great deal of SAS (<xref ref-type="supplementary-material" rid="SD1">SI Fig 6</xref>), in particular Y475 for SARS-Cov-1, and Y489 for SARS-Cov-2.</p></sec><sec id="S22"><title>Interface composition</title><p id="P57">We proceed with the inspection of the number of interface a.a., using the 14 a.a. reported in [<xref ref-type="bibr" rid="R35">35</xref>] as baseline.</p><p id="P58">Focusing on the RBD of SARS-Cov-1, we note that this number is precisely 29 for the crystal structures used (<xref ref-type="fig" rid="F2">Fig. 2</xref>, MISA/SSE). It should be stressed that the this is not an artifact since two atoms are in contact in a Voronoi model provided that their Voronoi restrictions intersect. (Nb: the restriction of a ball is the intersection of the atomic ball and the Voronoi/power region.) We note in particular that three residues omitted from [<xref ref-type="bibr" rid="R35">35</xref>] have BSA larger than 30 √Ö<sup>2</sup>in (2ajf, chain E): L443: 34.93 √Ö<sup>2</sup>, P462: 49.79 √Ö<sup>2</sup>, and I489: 32.87 √Ö<sup>2</sup>(jupyter notebook).</p><p id="P59">Switching to SARS-Cov-2, these numbers are 27 and 39 respectively, for the aforementioned two crystal structures‚Äìa discrepancy owing to solvation by structural water. Letting these count alone, a merit of MISAs appears immediately: as opposed to previous presentations, which single out the 14 a.a. of interest in the whole RBM sequence, it appears immediately that the interface a.a. are located within five main stretches along the sequence.</p><p id="P60">Interface strings in MISAs also single out the relatively high abundance of tyrosine (Y), and glycine (G) amongst interacting residues. Such a.a. have been shown to cooperatively account for specific recognition in particular in antibody-antigen interactions [<xref ref-type="bibr" rid="R37">37</xref>]. The role of tyrosines at interfaces is well documented [<xref ref-type="bibr" rid="R38">38</xref>], both in terms on interaction types (non polar, cation-pi and H bonds) and dynamics (the rigid side chain entails a lesser entropic penalty upon binding). Again, this is not visible from previous representations [<xref ref-type="bibr" rid="R25">25</xref>, <xref ref-type="supplementary-material" rid="SD1">SI Fig 1</xref>], [<xref ref-type="bibr" rid="R24">24</xref>, <xref ref-type="fig" rid="F2">Fig 2B</xref>], and [<xref ref-type="bibr" rid="R27">27</xref>, <xref ref-type="fig" rid="F2">Fig 2C</xref>] since the interface amino acids are not identified in a systematic manner.</p></sec><sec id="S23"><title>Conformational changes and binding affinity</title><p id="P61">MISA/SSE show that the RBD of SARS-Cov-2 is much less structured than that of SARS-Cov-1: while all residues are resolved in the unbound structures of SARS-Cov-1, a total of 12 of them are not so in the unbound structures of SARS-Cov-2 processed here (* in the i-strings, <xref ref-type="fig" rid="F2">Fig. 2</xref>). The a.a. concerned are nonpolar (AGGF) or uncharged polar (NSY). Hydrophobic patches on protein surfaces are notorious and contribute to the recognition of cognate substrates [<xref ref-type="bibr" rid="R39">39</xref>]. The balance observed here hints at a rather hydrophobic patch also preserving the ability to make hydrogen bonds via NSY. The color changes in MISA/SSE convey the same information: more frequent color changes for SARS-Cov-2 show that binding triggers more significant changes of hydrogen bonding patterns.</p><p id="P62">The analysis of MISA/?ASAcomplements this view (<xref ref-type="supplementary-material" rid="SD1">SI Fig. 6</xref>). For SARS-Cov-1, the interface a.a. have a balanced behavior, some gaining some loosing ASA, in the mild range (-10..+30√Ö<sup>2</sup>). For SARS-Cov-2 on the other hand, the scale is shifted towards negative values (&lt; ‚àí150.. + 35√Ö<sup>2</sup>). In other words, the binding entails a compactification of the RBD in SARS-Cov-2.</p><p id="P63">Speaking of conformational changes, we further our analysis with a clustering of structures in terms of lRMSD, which is of special interest to assess the conformational changes between the up and down conformation of the RBD. In this case, no significant difference is observed in terms of lRMSD computed from all backbone atoms (<xref ref-type="supplementary-material" rid="SD1">SI Fig. 7</xref>). Phrased differently, MISAs show subtle details at the individual a.a. level, which are overlooked by global lRMSD calculation.</p><p id="P64">Concluding, the previous discussion shed lights on the determinants of the affinity of the RBDs of SARS-Cov-1 and SARS-Cov-2 for their receptors [<xref ref-type="bibr" rid="R23">23</xref>]. For SARS-Cov-2, the unstructured nature hints at a large entropic penalty upon binding. This penalty is clearly counterbalanced by a strong enthalpic component in the dissociation free energy, which we see in particular from the BSA.</p></sec></sec><sec id="S24"><label>3.3</label><title>Interactions between the RBD of SARS-Cov-2 and antibodies</title><p id="P65">Neutralizing antibodies targeting the spikes of viruses can implement various strategies [<xref ref-type="bibr" rid="R40">40</xref>], including (i) masking the RBD, (ii) preventing the conformational changes triggering the fusion envelope-membrane, or may be more surprisingly by (iii) mimicking the receptor and triggering early conformational changes of the fusion machinery far away from the cell membrane [<xref ref-type="bibr" rid="R28">28</xref>]. We illustrate again the interest of MISAs in this context.</p><p id="P66">We first consider the complex (SARS-Cov-2-RBD, IG CR3022), the latter being an IG isolated from a convalescent SARS patient. Since this IG also targets the RBD, two critical questions are investigated in [<xref ref-type="bibr" rid="R22">22</xref>]: first, the comparison of the complexes complexes SARS-Cov-1-RBD with CR3022 and SARS-Cov-2-RBD with CR3022, so as to understand in particular the lesser binding affinity of CR3022 for SARS-Cov-2- RBD (Kd=115nM versus Kd=1nM); second, the absence of in vitro neutralization of SARS-Cov-2 by CR3022, taking into in particular the up/down conformations of the RBD and the role of glycosylation.</p><p id="P67">Interestingly, the first point use MISAs prepared <italic>by hand</italic> [22, Fig. 2A]. The systematic nature our automatically generated MISA/SSE shows modest albeit interesting refinements. First, one sees immediately that the regions of the RBD targeted by ACE2 and CR3022 are disjoint (<xref ref-type="fig" rid="F3">Figs. 3</xref> and <xref ref-type="fig" rid="F4">4</xref>; jupyter notebook). Second, using the two complexes RBD-CR3022 in the asymmetric unit of the crystal, we note that the interface involves 33 rather than 28 a.a. which bury surface area. Those omitted from [<xref ref-type="bibr" rid="R22">22</xref>, <xref ref-type="fig" rid="F2">Fig. 2A</xref>] are sitting on the boundary of the interface though (<xref ref-type="fig" rid="F3">Fig. 3(B, VdW balls)</xref>). MISA/BSA and MISA/ ŒîASAalso immediately identify those a.a. with the largest contribution to BSA (<xref ref-type="supplementary-material" rid="SD1">Figs. 8 and 9</xref>). Interestingly too, we note that binding with CR3022 triggers significant conformational changes with significant loss (Y380) or gain (H519) of ASA, as evidence by MISA/ Œî ASA.</p><p id="P68">As a final illustration, we also compare the interface (SARS-Cov-2-RBD, ACE2) against that of (SARS-Cov-2-RBD, P2B-2F6) [<xref ref-type="bibr" rid="R30">30</xref>]. With 10 shared residues, 10 exclusive residues for RBD - P2B-2F6, and 29 exclusive residues for RBD - ACE2, this comparison shows a clear competition between the two binders (jupyter notebook). A direct comparison against the 12 residues reported in [<xref ref-type="bibr" rid="R30">30</xref>] also shows that 8 residues reported by the Voronoi model have been omitted (<xref ref-type="fig" rid="F3">Fig. 3(C, VdW balls)</xref>). Of particular interest are R346 (BSA: 18.18√Ö<sup>2</sup>) and T470 (BSA: 21.02√Ö<sup>2</sup>). This illustrated again the systematic character of MISAs.</p></sec></sec><sec id="S25"><label>4</label><title>Outlook</title><p id="P69">The study of biomolecular interactions benefits from experimental and theoretical methods. On the experimental side, structure determination methods provide atomic coordinates for (ensembles) of structures, while thermodynamic/kinetic studies ambition to measure binding affinities and the underlying kinetic properties. Such experiments are often conducted in conjunction with directed mutagenesis, to unveil the specific role of amino acids. On the theoretical side, structure, thermodynamics and kinetics are studied using two classes of methods, namely interaction based methods, and learning based methods. As the name suggest, interaction based methods rely on covalent and non covalent potential energies models and associated force fields. Example such interactions are salt bridges, hydrogen bonds, <italic>œÄ</italic> stacking, etc. Such models generally have a limited spatial and time resolution, which imposes simulation methods to compute observables by means of averages over ensembles. Unfortunately, properties on long time scales are generally out of reach, so that qualitative descriptors of interaction patterns are resorted to. On the other hand, learning based method typically mix geometry based models with biochemical annotations, so as to design proxys for the key determinants of affinity and specificity. Such descriptors are known to be robust, and under suitable hypothesis, have proven good enough to estimate reliably binding affinities.</p><p id="P70">As illustrated by the example of the RBD of coronaviruses, most studies performed recently tend to promote specific interactions, usually backed up experimentally. This strategy is not entirely satisfactory, and one may actually quote [<xref ref-type="bibr" rid="R35">35</xref>] on the interaction (SARS-Cov-1-RBD, ACE2): ‚Äú <italic>The residues singled (authors‚Äô note: the 14 a.a.) out for description in the preceding paragraphs are not, of course, the only ones critical for the tight complementarity of the SARS-CoV RBD and human (or palm civet) ACE2.</italic>‚Äù. To promote a more comprehensive approach, we introduce MISAs, namely alignments between interface strings defined from geometric models, and coding biological / biophysical properties of interest. While Voronoi interface models are admittedly less precise than interaction based models, they are exhaustive/systematic, parameter free, and can be pulled back onto sequences. The encoding of interactions obtained, called <italic>interface strings</italic>, provides a concise way to capture global and local properties of complexes involving related proteins at a glance, as illustrated while analysis the RBD of coronaviruses.</p><p id="P71">We anticipate that the encoding of interfaces obtained will become a standard way to concisely represent interactions for families of homologous molecules, helping to understand protein interactions, identify critical residues, and therefore design therapeutics.</p></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary Materials</label><media xlink:href="EMS162888-supplement-Supplementary_Materials.pdf" mimetype="application" mime-subtype="pdf" id="d225aAdEbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S26"><title>Acknowledgment</title><p>T. Dreyfus is acknowledged for insightful comments.</p></ack><ref-list><ref id="R1"><label>[1]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janin</surname><given-names>J</given-names></name><name><surname>Bahadur</surname><given-names>RP</given-names></name><name><surname>Chakrabarti</surname><given-names>P</given-names></name></person-group><article-title>Protein-protein interaction and quaternary structure</article-title><source>Quarterly reviews of biophysics</source><year>2008</year><volume>41</volume><issue>2</issue><fpage>133</fpage><lpage>180</lpage><pub-id pub-id-type="pmid">18812015</pub-id></element-citation></ref><ref id="R2"><label>[2]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>H-X</given-names></name><name><surname>Gilson</surname><given-names>M</given-names></name></person-group><article-title>Theory of free energy and entropy in noncovalent binding</article-title><source>Chemical reviews</source><year>2009</year><volume>109</volume><issue>9</issue><fpage>4092</fpage><lpage>4107</lpage><pub-id pub-id-type="pmcid">PMC3329805</pub-id><pub-id pub-id-type="pmid">19588959</pub-id><pub-id pub-id-type="doi">10.1021/cr800551w</pub-id></element-citation></ref><ref id="R3"><label>[3]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>DE</given-names></name><name><surname>Maragakis</surname><given-names>P</given-names></name><name><surname>Lindorff-Larsen</surname><given-names>K</given-names></name><name><surname>Piana</surname><given-names>S</given-names></name><name><surname>Dror</surname><given-names>RO</given-names></name><name><surname>Eastwood</surname><given-names>MP</given-names></name><name><surname>Bank</surname><given-names>JA</given-names></name><name><surname>Jumper</surname><given-names>JM</given-names></name><name><surname>Salmon</surname><given-names>JK</given-names></name><name><surname>Shan</surname><given-names>Y</given-names></name><name><surname>Wriggers</surname><given-names>W</given-names></name></person-group><article-title>Atomic-level characterization of the structural dynamics of proteins</article-title><source>Science</source><year>2010</year><volume>330</volume><issue>6002</issue><fpage>341</fpage><lpage>346</lpage><pub-id pub-id-type="pmid">20947758</pub-id></element-citation></ref><ref id="R4"><label>[4]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Shi</given-names></name><name><surname>Wiewiora Rafal</surname><given-names>P</given-names></name><name><surname>Meng</surname><given-names>Fanwang</given-names></name><name><surname>Babault</surname><given-names>Nicolas</given-names></name><name><surname>Ma</surname><given-names>Anqi</given-names></name><name><surname>Yu</surname><given-names>Wenyu</given-names></name><name><surname>Qian</surname><given-names>Kun</given-names></name><name><surname>Hu</surname><given-names>Hao</given-names></name><name><surname>Zou</surname><given-names>Hua</given-names></name><name><surname>Wang</surname><given-names>Junyi</given-names></name><name><surname>Fan</surname><given-names>Shijie</given-names></name><etal/></person-group><article-title>The dynamic conformational landscape of the protein methyltransferase SETD8</article-title><source>eLife</source><year>2019</year><month>may</month><volume>8</volume><elocation-id>e45403</elocation-id><pub-id pub-id-type="pmcid">PMC6579520</pub-id><pub-id pub-id-type="pmid">31081496</pub-id><pub-id pub-id-type="doi">10.7554/eLife.45403</pub-id></element-citation></ref><ref id="R5"><label>[5]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richards</surname><given-names>F</given-names></name></person-group><article-title>The interpretation of protein structures: total volume, group volume distributions and packing density</article-title><source>Journal of molecular biology</source><year>1974</year><volume>82</volume><issue>1</issue><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">4818482</pub-id></element-citation></ref><ref id="R6"><label>[6]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chothia</surname><given-names>C</given-names></name><name><surname>Janin</surname><given-names>J</given-names></name></person-group><article-title>Principles of protein-protein recognition</article-title><source>Nature</source><year>1975</year><volume>256</volume><fpage>705</fpage><lpage>708</lpage><pub-id pub-id-type="pmid">1153006</pub-id></element-citation></ref><ref id="R7"><label>[7]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marillet</surname><given-names>S</given-names></name><name><surname>Boudinot</surname><given-names>P</given-names></name><name><surname>Cazals</surname><given-names>F</given-names></name></person-group><article-title>High resolution crystal structures leverage protein binding affinity predictions</article-title><source>Proteins: structure, function, and bioinformatics</source><year>2015</year><volume>1</volume><issue>84</issue><fpage>9</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">26471944</pub-id></element-citation></ref><ref id="R8"><label>[8]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cazals</surname><given-names>F</given-names></name><name><surname>Proust</surname><given-names>F</given-names></name><name><surname>Bahadur</surname><given-names>R</given-names></name><name><surname>Janin</surname><given-names>J</given-names></name></person-group><article-title>Revisiting the Voronoi description of protein-protein interfaces</article-title><source>Protein Science</source><year>2006</year><volume>15</volume><issue>9</issue><fpage>2082</fpage><lpage>2092</lpage><pub-id pub-id-type="pmcid">PMC2242599</pub-id><pub-id pub-id-type="pmid">16943442</pub-id><pub-id pub-id-type="doi">10.1110/ps.062245906</pub-id></element-citation></ref><ref id="R9"><label>[9]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olechnoviƒç</surname><given-names>Kliment</given-names></name><name><surname>Venclovas</surname><given-names>ƒåeslovas</given-names></name></person-group><article-title>Voronota: a fast and reliable tool for computing the vertices of the voronoi diagram of atomic balls</article-title><source>Journal of computational chemistry</source><year>2014</year><volume>35</volume><issue>8</issue><fpage>672</fpage><lpage>681</lpage><pub-id pub-id-type="pmid">24523197</pub-id></element-citation></ref><ref id="R10"><label>[10]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bahadur</surname><given-names>Ranjit Prasad</given-names></name><name><surname>Chakrabarti</surname><given-names>Pinak</given-names></name><name><surname>Rodier</surname><given-names>Francis</given-names></name><name><surname>Janin</surname><given-names>Jo√´l</given-names></name></person-group><article-title>A dissection of specific and non-specific protein‚Äìprotein interfaces</article-title><source>Journal of molecular biology</source><year>2004</year><volume>336</volume><issue>4</issue><fpage>943</fpage><lpage>955</lpage><pub-id pub-id-type="pmid">15095871</pub-id></element-citation></ref><ref id="R11"><label>[11]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marillet</surname><given-names>S</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name><name><surname>Boudinot</surname><given-names>P</given-names></name><name><surname>Cazals</surname><given-names>F</given-names></name></person-group><article-title>Novel structural parameters of ig‚Äìag complexes yield a quantitative description of interaction specificity and binding affinity</article-title><source>Frontiers in immunology</source><year>2017</year><volume>34</volume><issue>8</issue><pub-id pub-id-type="pmcid">PMC5298999</pub-id><pub-id pub-id-type="pmid">28232828</pub-id><pub-id pub-id-type="doi">10.3389/fimmu.2017.00034</pub-id></element-citation></ref><ref id="R12"><label>[12]</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Pevsner</surname><given-names>J</given-names></name></person-group><source>Bioinformatics and functional genomics</source><publisher-name>John Wiley &amp; Sons</publisher-name><year>2015</year></element-citation></ref><ref id="R13"><label>[13]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cazals</surname><given-names>F</given-names></name><name><surname>Dreyfus</surname><given-names>T</given-names></name></person-group><article-title>The Structural Bioinformatics Library: modeling in biomolecular science and beyond</article-title><source>Bioinformatics</source><year>2017</year><volume>7</volume><issue>33</issue><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">28062450</pub-id></element-citation></ref><ref id="R14"><label>[14]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loriot</surname><given-names>S</given-names></name><name><surname>Cazals</surname><given-names>F</given-names></name></person-group><article-title>Modeling macro-molecular interfaces with Intervor</article-title><source>Bioinformatics</source><year>2010</year><volume>26</volume><issue>7</issue><fpage>964</fpage><lpage>965</lpage><pub-id pub-id-type="pmid">20139468</pub-id></element-citation></ref><ref id="R15"><label>[15]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabsch</surname><given-names>W</given-names></name><name><surname>Sander</surname><given-names>C</given-names></name></person-group><article-title>Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features</article-title><source>Biopolymers: Original Research on Biomolecules</source><year>1983</year><volume>22</volume><issue>12</issue><fpage>2577</fpage><lpage>2637</lpage><pub-id pub-id-type="pmid">6667333</pub-id></element-citation></ref><ref id="R16"><label>[16]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cazals</surname><given-names>F</given-names></name><name><surname>Kanhere</surname><given-names>H</given-names></name><name><surname>Loriot</surname><given-names>S</given-names></name></person-group><article-title>Computing the volume of union of balls: a certified algorithm</article-title><source>ACM Transactions on Mathematical Software</source><year>2011</year><volume>38</volume><issue>1</issue><fpage>1</fpage><lpage>20</lpage></element-citation></ref><ref id="R17"><label>[17]</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Cazals</surname><given-names>F</given-names></name></person-group><source>Revisiting the Voronoi description of protein-protein interfaces: Algorithms</source><person-group person-group-type="editor"><name><surname>Dijkstra</surname><given-names>T</given-names></name><name><surname>Tsivtsivadze</surname><given-names>E</given-names></name><name><surname>Marchiori</surname><given-names>E</given-names></name><name><surname>Heskes</surname><given-names>T</given-names></name></person-group><conf-name>International Conference on Pattern Recognition in Bioinformatics</conf-name><conf-sponsor>Nijmegen</conf-sponsor><conf-loc>Netherlands</conf-loc><series>Lecture Notes in Bioinformatics 6282</series><year>2010</year><fpage>419</fpage><lpage>430</lpage></element-citation></ref><ref id="R18"><label>[18]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Lei</given-names></name><name><surname>Song</surname><given-names>Guang</given-names></name><name><surname>Jernigan</surname><given-names>Robert L</given-names></name></person-group><article-title>Comparisons of experimental and computed protein anisotropic temperature factors</article-title><source>Proteins: Structure, Function, and Bioinformatics</source><year>2009</year><volume>76</volume><issue>1</issue><fpage>164</fpage><lpage>175</lpage><pub-id pub-id-type="pmcid">PMC2775930</pub-id><pub-id pub-id-type="pmid">19127591</pub-id><pub-id pub-id-type="doi">10.1002/prot.22328</pub-id></element-citation></ref><ref id="R19"><label>[19]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tortorici</surname><given-names>M Alejandra</given-names></name><name><surname>Veesler</surname><given-names>David</given-names></name></person-group><article-title>Structural insights into coronavirus entry</article-title><source>Advances in virus research</source><year>2019</year><volume>105</volume><fpage>93</fpage><lpage>116</lpage><pub-id pub-id-type="pmcid">PMC7112261</pub-id><pub-id pub-id-type="pmid">31522710</pub-id><pub-id pub-id-type="doi">10.1016/bs.aivir.2019.08.002</pub-id></element-citation></ref><ref id="R20"><label>[20]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>SC</given-names></name></person-group><article-title>Viral membrane fusion</article-title><source>Virology</source><year>2015</year><volume>479-480</volume><fpage>498</fpage><lpage>507</lpage><pub-id pub-id-type="pmcid">PMC4424100</pub-id><pub-id pub-id-type="pmid">25866377</pub-id><pub-id pub-id-type="doi">10.1016/j.virol.2015.03.043</pub-id></element-citation></ref><ref id="R21"><label>[21]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wrapp</surname><given-names>Daniel</given-names></name><name><surname>Wang</surname><given-names>Nianshuang</given-names></name><name><surname>Corbett</surname><given-names>Kizzmekia S</given-names></name><name><surname>Goldsmith</surname><given-names>Jory A</given-names></name><name><surname>Hsieh</surname><given-names>Ching-Lin</given-names></name><name><surname>Olubukola</surname><given-names>Abiona</given-names></name><name><surname>Graham</surname><given-names>Barney S</given-names></name><name><surname>McLellan</surname><given-names>Jason S</given-names></name></person-group><article-title>Cryo-em structure of the 2019-ncov spike in the prefusion conformation</article-title><source>Science</source><year>2020</year><volume>367</volume><issue>6483</issue><fpage>1260</fpage><lpage>1263</lpage><pub-id pub-id-type="pmcid">PMC7164637</pub-id><pub-id pub-id-type="pmid">32075877</pub-id><pub-id pub-id-type="doi">10.1126/science.abb2507</pub-id></element-citation></ref><ref id="R22"><label>[22]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>Meng</given-names></name><name><surname>Wu</surname><given-names>Nicholas C</given-names></name><name><surname>Zhu</surname><given-names>Xueyong</given-names></name><name><surname>Lee</surname><given-names>Chang-Chun D</given-names></name><name><surname>So</surname><given-names>Ray TY</given-names></name><name><surname>Huibin</surname><given-names>Lv</given-names></name><name><surname>Mok</surname><given-names>Chris KP</given-names></name><name><surname>Wilson</surname><given-names>Ian A</given-names></name></person-group><article-title>A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV</article-title><source>Science</source><year>2020</year><volume>368</volume><issue>6491</issue><fpage>630</fpage><lpage>633</lpage><pub-id pub-id-type="pmcid">PMC7164391</pub-id><pub-id pub-id-type="pmid">32245784</pub-id><pub-id pub-id-type="doi">10.1126/science.abb7269</pub-id></element-citation></ref><ref id="R23"><label>[23]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shang</surname><given-names>J</given-names></name><name><surname>Wan</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>C</given-names></name><name><surname>Ye</surname><given-names>G</given-names></name><name><surname>Geng</surname><given-names>Q</given-names></name><name><surname>Auerbach</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>F</given-names></name></person-group><article-title>Cell entry mechanisms of SARS-CoV-2</article-title><source>PNAS</source><year>2020</year><fpage>1</fpage><lpage>8</lpage><comment>NA(NA)</comment><pub-id pub-id-type="pmcid">PMC7260975</pub-id><pub-id pub-id-type="pmid">32376634</pub-id><pub-id pub-id-type="doi">10.1073/pnas.2003138117</pub-id></element-citation></ref><ref id="R24"><label>[24]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>Markus</given-names></name><name><surname>Kleine-Weber</surname><given-names>Hannah</given-names></name><name><surname>Schroeder</surname><given-names>Simon</given-names></name><name><surname>Kr√ºger</surname><given-names>Nadine</given-names></name><name><surname>Herrler</surname><given-names>Tanja</given-names></name><name><surname>Erichsen</surname><given-names>Sandra</given-names></name><name><surname>Schiergens</surname><given-names>Tobias S</given-names></name><name><surname>Herrler</surname><given-names>Georg</given-names></name><name><surname>Nai-Huei</surname><given-names>Wu</given-names></name><name><surname>Nitsche</surname><given-names>Andreas</given-names></name><etal/></person-group><article-title>Sars-cov-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor</article-title><source>Cell</source><year>2020</year><pub-id pub-id-type="pmcid">PMC7102627</pub-id><pub-id pub-id-type="pmid">32142651</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2020.02.052</pub-id></element-citation></ref><ref id="R25"><label>[25]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shang</surname><given-names>Jian</given-names></name><name><surname>Ye</surname><given-names>Gang</given-names></name><name><surname>Shi</surname><given-names>Ke</given-names></name><name><surname>Wan</surname><given-names>Yushun</given-names></name><name><surname>Luo</surname><given-names>Chuming</given-names></name><name><surname>Aihara</surname><given-names>Hideki</given-names></name><name><surname>Geng</surname><given-names>Qibin</given-names></name><name><surname>Auerbach</surname><given-names>Ashley</given-names></name><name><surname>Li</surname><given-names>Fang</given-names></name></person-group><article-title>Structural basis of receptor recognition by SARS-CoV-2</article-title><source>Nature</source><year>2020</year><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="pmcid">PMC7328981</pub-id><pub-id pub-id-type="pmid">32225175</pub-id><pub-id pub-id-type="doi">10.1038/s41586-020-2179-y</pub-id></element-citation></ref><ref id="R26"><label>[26]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Renhong</given-names></name><name><surname>Zhang</surname><given-names>Yuanyuan</given-names></name><name><surname>Li</surname><given-names>Yaning</given-names></name><name><surname>Lu</surname><given-names>Xia</given-names></name><name><surname>Guo</surname><given-names>Yingying</given-names></name><name><surname>Zhou</surname><given-names>Qiang</given-names></name></person-group><article-title>Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2</article-title><source>Science</source><year>2020</year><volume>367</volume><issue>6485</issue><fpage>1444</fpage><lpage>1448</lpage><pub-id pub-id-type="pmcid">PMC7164635</pub-id><pub-id pub-id-type="pmid">32132184</pub-id><pub-id pub-id-type="doi">10.1126/science.abb2762</pub-id></element-citation></ref><ref id="R27"><label>[27]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walls</surname><given-names>Alexandra C</given-names></name><name><surname>Park</surname><given-names>Young-Jun</given-names></name><name><surname>Alejandra Tortorici</surname><given-names>M</given-names></name><name><surname>Wall</surname><given-names>Abigail</given-names></name><name><surname>McGuire</surname><given-names>Andrew T</given-names></name><name><surname>Veesler</surname><given-names>David</given-names></name></person-group><article-title>Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein</article-title><source>Cell</source><year>2020</year><pub-id pub-id-type="pmcid">PMC7102599</pub-id><pub-id pub-id-type="pmid">32155444</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2020.02.058</pub-id></element-citation></ref><ref id="R28"><label>[28]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walls</surname><given-names>Alexandra C</given-names></name><name><surname>Xiong</surname><given-names>Xiaoli</given-names></name><name><surname>Park</surname><given-names>Young-Jun</given-names></name><name><surname>Alejandra Tortorici</surname><given-names>M</given-names></name><name><surname>Snijder</surname><given-names>Joost</given-names></name><name><surname>Quispe</surname><given-names>Joel</given-names></name><name><surname>Cameroni</surname><given-names>Elisabetta</given-names></name><name><surname>Gopal</surname><given-names>Robin</given-names></name><name><surname>Dai</surname><given-names>Mian</given-names></name><name><surname>Lanzavecchia</surname><given-names>Antonio</given-names></name><etal/></person-group><article-title>Unexpected receptor functional mimicry elucidates activation of coronavirus fusion</article-title><source>Cell</source><year>2019</year><volume>176</volume><issue>5</issue><fpage>1026</fpage><lpage>1039</lpage><pub-id pub-id-type="pmcid">PMC6751136</pub-id><pub-id pub-id-type="pmid">30712865</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2018.12.028</pub-id></element-citation></ref><ref id="R29"><label>[29]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wrapp</surname><given-names>D</given-names></name><name><surname>De Vlieger</surname><given-names>D</given-names></name><name><surname>Corbett</surname><given-names>K</given-names></name><name><surname>Torres</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Van Breedam</surname><given-names>W</given-names></name><name><surname>van Schie Loes</surname><given-names>K</given-names></name><name><surname>Hoffmann</surname><given-names>M</given-names></name><name><surname>Pohlmann</surname><given-names>S</given-names></name><name><surname>Graham</surname><given-names>B</given-names></name><name><surname>Callewaert</surname><given-names>N</given-names></name><etal/></person-group><article-title>Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies</article-title><source>Cell</source><year>2020</year><pub-id pub-id-type="pmcid">PMC7199733</pub-id><pub-id pub-id-type="pmid">32375025</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2020.04.031</pub-id></element-citation></ref><ref id="R30"><label>[30]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ju</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Ge</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Ge</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Shan</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Song</surname><given-names>S</given-names></name></person-group><article-title>Human neutralizing antibodies elicited by sars-cov-2 infection</article-title><source>Nature</source><year>2020</year><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">32454513</pub-id></element-citation></ref><ref id="R31"><label>[31]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delmas</surname><given-names>BERNARDB</given-names></name><name><surname>Laude</surname><given-names>H</given-names></name></person-group><article-title>Assembly of coronavirus spike protein into trimers and its role in epitope expression</article-title><source>Journal of virology</source><year>1990</year><volume>64</volume><issue>11</issue><fpage>5367</fpage><lpage>5375</lpage><pub-id pub-id-type="pmcid">PMC248586</pub-id><pub-id pub-id-type="pmid">2170676</pub-id><pub-id pub-id-type="doi">10.1128/jvi.64.11.5367-5375.1990</pub-id></element-citation></ref><ref id="R32"><label>[32]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>F</given-names></name></person-group><article-title>Structure, function, and evolution of coronavirus spike proteins</article-title><source>Annual review of virology</source><year>2016</year><volume>3</volume><fpage>237</fpage><lpage>261</lpage><pub-id pub-id-type="pmcid">PMC5457962</pub-id><pub-id pub-id-type="pmid">27578435</pub-id><pub-id pub-id-type="doi">10.1146/annurev-virology-110615-042301</pub-id></element-citation></ref><ref id="R33"><label>[33]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walls</surname><given-names>Alexandra C</given-names></name><name><surname>Alejandra Tortorici</surname><given-names>M</given-names></name><name><surname>Snijder</surname><given-names>Joost</given-names></name><name><surname>Xiong</surname><given-names>Xiaoli</given-names></name><name><surname>Bosch</surname><given-names>Berend-Jan</given-names></name><name><surname>Rey</surname><given-names>Felix A</given-names></name><name><surname>Veesler</surname><given-names>David</given-names></name></person-group><article-title>Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion</article-title><source>Proceedings of the National Academy of Sciences</source><year>2017</year><volume>114</volume><issue>42</issue><fpage>11157</fpage><lpage>11162</lpage><pub-id pub-id-type="pmcid">PMC5651768</pub-id><pub-id pub-id-type="pmid">29073020</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1708727114</pub-id></element-citation></ref><ref id="R34"><label>[34]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaimes</surname><given-names>J</given-names></name><name><surname>Andr√©</surname><given-names>N</given-names></name><name><surname>Chappie</surname><given-names>J</given-names></name><name><surname>Millet</surname><given-names>J</given-names></name><name><surname>Whittaker</surname><given-names>G</given-names></name></person-group><article-title>Phylogenetic analysis and structural modeling of SARS-CoV-2 spike protein reveals an evolutionary distinct and proteolytically-sensitive activation loop</article-title><source>Journal of molecular biology</source><year>2020</year><volume>432</volume><fpage>3309</fpage><lpage>3325</lpage><pub-id pub-id-type="pmcid">PMC7166309</pub-id><pub-id pub-id-type="pmid">32320687</pub-id><pub-id pub-id-type="doi">10.1016/j.jmb.2020.04.009</pub-id></element-citation></ref><ref id="R35"><label>[35]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Fang</given-names></name><name><surname>Li</surname><given-names>Wenhui</given-names></name><name><surname>Farzan</surname><given-names>Michael</given-names></name><name><surname>Harrison</surname><given-names>Stephen C</given-names></name></person-group><article-title>Structure of SARS coronavirus spike receptor-binding domain complexed with receptor</article-title><source>Science</source><year>2005</year><volume>309</volume><issue>5742</issue><fpage>1864</fpage><lpage>1868</lpage><pub-id pub-id-type="pmid">16166518</pub-id></element-citation></ref><ref id="R36"><label>[36]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janin</surname><given-names>J</given-names></name></person-group><article-title>A minimal model of protein‚Äìprotein binding affinities</article-title><source>Protein Science</source><year>2014</year><volume>23</volume><issue>12</issue><fpage>1813</fpage><lpage>1817</lpage><pub-id pub-id-type="pmcid">PMC4253822</pub-id><pub-id pub-id-type="pmid">25270898</pub-id><pub-id pub-id-type="doi">10.1002/pro.2560</pub-id></element-citation></ref><ref id="R37"><label>[37]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birtalan</surname><given-names>Sara</given-names></name><name><surname>Zhang</surname><given-names>Yingnan</given-names></name><name><surname>Fellouse</surname><given-names>Frederic A</given-names></name><name><surname>Shao</surname><given-names>Lihua</given-names></name><name><surname>Schaefer</surname><given-names>Gabriele</given-names></name><name><surname>Sidhu</surname><given-names>Sachdev S</given-names></name></person-group><article-title>The intrinsic contributions of tyrosine, serine, glycine and arginine to the affinity and specificity of antibodies</article-title><source>Journal of molecular biology</source><year>2008</year><volume>377</volume><issue>5</issue><fpage>1518</fpage><lpage>1528</lpage><pub-id pub-id-type="pmid">18336836</pub-id></element-citation></ref><ref id="R38"><label>[38]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koide</surname><given-names>Shohei</given-names></name><name><surname>Sidhu</surname><given-names>Sachdev S</given-names></name></person-group><article-title>The importance of being tyrosine: lessons in molecular recognition from minimalist synthetic binding proteins</article-title><source>ACS chemical biology</source><year>2009</year><volume>4</volume><issue>5</issue><fpage>325</fpage><lpage>334</lpage><pub-id pub-id-type="pmcid">PMC2829252</pub-id><pub-id pub-id-type="pmid">19298050</pub-id><pub-id pub-id-type="doi">10.1021/cb800314v</pub-id></element-citation></ref><ref id="R39"><label>[39]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lijnzaad</surname><given-names>Philip</given-names></name><name><surname>Berendsen</surname><given-names>Herman JC</given-names></name><name><surname>Argos</surname><given-names>Patrick</given-names></name></person-group><article-title>Hydrophobic patches on the surfaces of protein structures</article-title><source>Proteins: Structure, Function, and Bioinformatics</source><year>1996</year><volume>25</volume><issue>3</issue><fpage>389</fpage><lpage>397</lpage><pub-id pub-id-type="pmid">8844873</pub-id></element-citation></ref><ref id="R40"><label>[40]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corti</surname><given-names>D</given-names></name><name><surname>Lanzavecchia</surname><given-names>A</given-names></name></person-group><article-title>Broadly neutralizing antiviral antibodies</article-title><source>Annual review of immunology</source><year>2013</year><volume>31</volume><fpage>705</fpage><lpage>742</lpage><pub-id pub-id-type="pmid">23330954</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>SARS-Cov-1 and SARS-Cov-2: Voronoi interfaces of the RBD in complex with ACE2. (Panel A)</title><p>Side view of the Voronoi interface, with contributing a.a. as new ribbons. Note in particular the many disconnected contributions of SSE of the RBD to the interface. <bold>(Panel B)</bold> Top view of the interface, with interface a.a. as ribbons, and their side chains in CPK mode. <bold>(Panel C)</bold> The four or five ranges of consecutive a.a. identified by MISA, with backbone in CPK mode, on top of the Voronoi interface. SARS-Cov-1: 390-396 (violet), 404-408 (blue), 426-443 (yellow), 460-463 (orange), 470-492 (red); SARS-Cov-2: 417-421 (blue), 439-456 (yellow), 473-477 (orange), 484-506 (red)</p></caption><graphic xlink:href="EMS162888-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>MISA/SSE for structures of <xref ref-type="fig" rid="F1">Fig. 1</xref>.</title></caption><graphic xlink:href="EMS162888-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>SARS-Cov-2 and SARS-Cov-1: RBD bound to the various IG / VHH: Voronoi interfaces.</title><p>(A) Complex with ACE2 presented for reference (A). (B) Complex from [<xref ref-type="bibr" rid="R22">22</xref>]. Residues in VdW mode are identified by the Voronoi interface model but are not listed in [<xref ref-type="bibr" rid="R22">22</xref>]. (C) Complex from [<xref ref-type="bibr" rid="R30">30</xref>]. Residues in VdW mode are identified by the Voronoi interface model but are not listed in [<xref ref-type="bibr" rid="R30">30</xref>].</p></caption><graphic xlink:href="EMS162888-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>MISA/SSE for structures of <xref ref-type="fig" rid="F3">Fig. 3</xref>.</title><p>MISA of ACE2 not shown.</p></caption><graphic xlink:href="EMS162888-f004"/></fig></floats-group></article>